Contrast-enhanced MR imaging of the breast: comparison of two different doses of gadopentetate dimeglumine

Radiology. 1994 Jun;191(3):639-46. doi: 10.1148/radiology.191.3.8184040.

Abstract

Purpose: To optimize detection and diagnosis of breast lesions with contrast-enhanced magnetic resonance (MR) imaging.

Materials and methods: A three-dimensional fast low-angle shot pulse sequence was used for a group comparison consisting of 76 high-dose (0.16 mmol gadopentetate dimeglumine per kilogram of body weight) and 76 low-dose (0.1 mmol/kg) examinations. Intraindividual comparisons were possible in a subgroup of 20 patients.

Results: Enhancement with the high dose was about 1.5 times higher for benign and malignant tissues. With the lower dose, no false-positive findings could be avoided and definition of a threshold that excluded false-negative findings was problematic. Conspicuity of malignant lesions was much improved with the higher dose (a good to excellent rating in 81% vs 26% with the lower dose). Three small foci were visible only with the higher dose.

Conclusion: The higher dose of contrast material allowed much better results. Dose comparison studies are also recommended for other techniques.

Publication types

  • Comparative Study

MeSH terms

  • Breast / pathology*
  • Breast Diseases / diagnosis
  • Breast Neoplasms / diagnosis
  • Carcinoma / diagnosis
  • Contrast Media / administration & dosage*
  • Drug Combinations
  • Female
  • Fibroadenoma / diagnosis
  • Fibrocystic Breast Disease / diagnosis
  • Gadolinium DTPA
  • Humans
  • Image Enhancement
  • Magnetic Resonance Imaging*
  • Meglumine* / administration & dosage
  • Organometallic Compounds* / administration & dosage
  • Pentetic Acid / administration & dosage
  • Pentetic Acid / analogs & derivatives*

Substances

  • Contrast Media
  • Drug Combinations
  • Organometallic Compounds
  • Meglumine
  • Pentetic Acid
  • Gadolinium DTPA